Osteosarcomas downregulate CXCL12, compromising leukocyte trafficking and allowing for tumor growth and metastasis.(15) Accordingly, strong expression of CXCL12 in osteosarcoma is associated with favorable prognosis.(16). The gene discussed is CXCL12; the disease is neoplasm.